De novo tacrolimus extended‐release tablets (LCPT) versus twice‐daily tacrolimus in adult heart transplantation: Results of a single‐center non‐inferiority matched control trial-Reference-Cited by-同舟云学术

De novo tacrolimus extended‐release tablets (LCPT) versus twice‐daily tacrolimus in adult heart transplantation: Results of a single‐center non‐inferiority matched control trial

Published:2021-10 Issue:12 Volume:35 Page:
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clinical Transplantation

Author:

van Zyl Johanna S.¹²^ORCID,Sam Teena³^ORCID,Clark Donna M.¹,Felius Joost¹²^ORCID,Doss Amanda K.¹,Kerlee Kacie R.²,Cheung Zi‐On²,Martits‐Chalangari Katalin¹,Jamil Aayla K.¹²^ORCID,Carey Sandra A.⁴^ORCID,Gottlieb Robert L.¹²⁴⁵^ORCID,Guerrero‐Miranda Cesar Y.¹²⁴,Kale Parag¹²⁴,Hall Shelley A.¹²⁴^ORCID

Affiliation:

1. Baylor Scott & White Research Institute Baylor Scott & White Health Dallas Texas USA

2. Texas A&M University College of Medicine Health Science Center Dallas Texas USA

3. Department of Pharmacy Baylor University Medical Center Baylor Scott & White Health Dallas Texas USA

4. Center for Advanced Heart and Lung Disease Baylor University Medical Center Baylor Scott & White Health Dallas Texas USA

5. Division of Precision Medicine Baylor University Medical Center Dallas Texas USA

Funder

Veloxis Pharmaceuticals

Publisher

Wiley

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ctr.14487

Reference34 articles.

1. Impact of different long-term maintenance immunosuppressive therapy strategies on patients' outcome after heart transplantation

2. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report — 2019; focus theme: Donor and recipient size match

3. Astellas Pharma US Inc.Prograf (Tacrolimus) Capsules/Injection [Package Insert].;2012. Accessed July 13 2020.https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050709s031lbl.pdf

4. Tacrolimus with Mycophenolate Mofetil (MMF) or Sirolimus vs. Cyclosporine with MMF in Cardiac Transplant Patients: 1-Year Report

5. Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help?

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemorrhagic events associated with tacrolimus: a real-world pharmacovigilance study;Expert Opinion on Drug Safety;2024-07-15

2. Three-year outcomes of de novo tacrolimus extended-release tablets (LCPT) compared to twice-daily tacrolimus in adult heart transplantation;Transplant Immunology;2024-04

3. Microneedle-mediated transdermal delivery of FK506 for treatment of acute cardiac allograft rejection;Materials & Design;2023-11

4. Voclosporin: Unique Chemistry, Pharmacology and Toxicity Profile, and Possible Options for Implementation into the Management of Lupus Nephritis;Cells;2023-10-11

5. Comparison of the Prolonged- and Immediate-Release Tacrolimus Capsule Formulation: The Patient's View and Medication Satisfaction of Patients After Pediatric Heart Transplantation;Transplantation Proceedings;2023-09